Skip to main content
. 2019 Oct;31(5):806–817. doi: 10.21147/j.issn.1000-9604.2019.05.10

5.

5

Recurrence-free survival (RFS) curves in high and low Ki-67 groups. RFS rates at 1 years in patients with high Ki-67 hepatocellular carcinoma (HCC) were significantly lower than that in patients with low Ki-67 HCC (63.27% vs. 85.00%, P=0.009 in log-rank test).